The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.425T>C (p.Phe142Ser)

CA220207

92283 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 3f32f6a5-2276-4bab-b736-853284e9704f

HGVS expressions

NM_000018.4:c.425T>C
NM_000018.4(ACADVL):c.425T>C (p.Phe142Ser)
NC_000017.11:g.7221006T>C
CM000679.2:g.7221006T>C
NC_000017.10:g.7124325T>C
CM000679.1:g.7124325T>C
NC_000017.9:g.7065049T>C
NG_007975.1:g.6173T>C
NG_008391.2:g.4045A>G
ENST00000356839.10:c.425T>C
ENST00000322910.9:c.*380T>C
ENST00000350303.9:c.359T>C
ENST00000356839.9:c.425T>C
ENST00000543245.6:c.494T>C
ENST00000577191.5:n.502T>C
ENST00000577433.5:n.633T>C
ENST00000577857.5:n.293+176T>C
ENST00000579286.5:n.606T>C
ENST00000579886.2:c.263T>C
ENST00000580365.1:n.156T>C
ENST00000581378.5:n.124T>C
ENST00000581562.5:n.472T>C
ENST00000582056.5:n.608T>C
ENST00000582166.1:n.406T>C
ENST00000583312.5:c.425T>C
ENST00000584103.5:c.458T>C
NM_000018.3:c.425T>C
NM_001033859.2:c.359T>C
NM_001270447.1:c.494T>C
NM_001270448.1:c.197T>C
NM_001033859.3:c.359T>C
NM_001270447.2:c.494T>C
NM_001270448.2:c.197T>C

Uncertain Significance

Met criteria codes 4
PM2_Supporting PM3_Supporting PP4 PP3
Not Met criteria codes 6
PVS1 PP1 PM4 PM1 PM5 PS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.425T>C variant in ACADVL is a missense variant predicted to cause substitution of phenylalanine by serine at amino acid 142 (p.Phe142Ser). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.94, which is above the threshold 0.75, evidence that correlates with impact to ACADVL function (PP3). At least one patient with this variant displayed organic acidemia and fatty acid oxidation issues, which are highly specific for VLCAD deficiency (PP4, PMID: 27629047, PMID: 28980192). This individual was also reported homozygous for the variant (PMID: 27629047; points=0.5; PM3_supporting). In summary, this variant meets the criteria to be classified as VUS for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PM2,PM3_supporting PP3, PP4
Met criteria codes
PM2_Supporting
c.425T>C is not found in gnomAD or 1000 Genome projects
PM3_Supporting
Described as homozygote in one patient (Table 3). 0.5 point = PM3_supporting
PP4
One proband case was found (Saudi Arabia) and diagnosed with VLCAD deficiency. Only a phenotypic description was given - no enzyme level or acylcarnitine analysis data.
PP3
REVEL score is 0.944 which passes the ACADVL criteria of greater than 0.75
Not Met criteria codes
PVS1
variant is missense, not covered by PVS1
PP1
No segregation data found
PM4
Phe142Ser does not alter protein length
PM1
Phe142 is not located in a designated hotspot or functional domain
PM5
No other missense change seen at this residue
PS1
No other codon change seen to cause F142S
Approved on: 2022-12-14
Published on: 2022-12-14
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.